Michael J. Morin

1.8k total citations · 1 hit paper
21 papers, 1.5k citations indexed

About

Michael J. Morin is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michael J. Morin has authored 21 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michael J. Morin's work include Glycosylation and Glycoproteins Research (3 papers), Cancer Research and Treatments (3 papers) and Cancer therapeutics and mechanisms (3 papers). Michael J. Morin is often cited by papers focused on Glycosylation and Glycoproteins Research (3 papers), Cancer Research and Treatments (3 papers) and Cancer therapeutics and mechanisms (3 papers). Michael J. Morin collaborates with scholars based in United States, Canada and Italy. Michael J. Morin's co-authors include Barbara A. Foster, Farzan Rastinejad, Ralph J. Bernacki, Lee D. Arnold, Deborah A. Baker, Teresa A. Smolarek, Leslie R. Pustilnik, Vincent A. Pollack, John A. Davis and Kenneth K. Iwata and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael J. Morin

21 papers receiving 1.4k citations

Hit Papers

Pharmacological Rescue of Mutant p53 Conformation and Fun... 1999 2026 2008 2017 1999 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pharmacological Rescue of Mutant p53 Conformation and Function
    1999 647 citations Barbara A. Foster, Michael J. Morin et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Morin United States 11 847 841 253 163 154 21 1.5k
James Tsai United States 16 1.1k 1.3× 757 0.9× 238 0.9× 218 1.3× 39 0.3× 27 1.8k
Hisao Fukumoto Japan 17 587 0.7× 432 0.5× 193 0.8× 119 0.7× 62 0.4× 30 1.0k
Christine M. Chresta United Kingdom 21 1.5k 1.7× 827 1.0× 207 0.8× 107 0.7× 69 0.4× 33 2.1k
Masashi Aonuma Japan 11 1.2k 1.4× 875 1.0× 118 0.5× 128 0.8× 50 0.3× 14 1.5k
I Bae United States 7 1.1k 1.3× 1.1k 1.3× 107 0.4× 71 0.4× 212 1.4× 8 1.6k
Sheng-Chieh Hsu Taiwan 16 1.0k 1.2× 811 1.0× 286 1.1× 51 0.3× 82 0.5× 16 1.7k
Christine Stephan Switzerland 11 886 1.0× 392 0.5× 239 0.9× 59 0.4× 54 0.4× 20 1.3k
Sébastien Jeay Switzerland 24 1.1k 1.3× 631 0.8× 176 0.7× 90 0.6× 57 0.4× 46 1.8k
Lily L. Remsing Rix United States 19 902 1.1× 429 0.5× 179 0.7× 260 1.6× 41 0.3× 28 1.8k
Donald Thornton United States 19 890 1.1× 672 0.8× 372 1.5× 121 0.7× 33 0.2× 37 1.9k

Countries citing papers authored by Michael J. Morin

Since Specialization
Citations

This map shows the geographic impact of Michael J. Morin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Morin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Morin more than expected).

Fields of papers citing papers by Michael J. Morin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Morin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Morin. The network helps show where Michael J. Morin may publish in the future.

Co-authorship network of co-authors of Michael J. Morin

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Morin. A scholar is included among the top collaborators of Michael J. Morin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Morin. Michael J. Morin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cremona, Marzia A., et al.. (2025). A data-driven personalized approach to predict blood glucose levels in type-1 diabetes patients exercising in free-living conditions. Computers in Biology and Medicine. 190. 110015–110015. 3 indexed citations
2.
Morin, Michael J., et al.. (2024). Recurrent high grade serous endometrial cancer with brain metastases: Immunotherapy confers improved quality of life and survival. Gynecologic Oncology Reports. 55. 101494–101494. 1 indexed citations
3.
Dowling, John P., Pavel A. Nikitin, Fang Shen, et al.. (2023). IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activation. mAbs. 15(1). 2212673–2212673. 7 indexed citations
4.
DiMuzio, Jillian, John P. Dowling, Antonio Polley, et al.. (2021). Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike protein. Vaccine X. 8. 100098–100098. 6 indexed citations
5.
Morin, Michael J., et al.. (2020). Safety and Effectiveness of a Novel Fluoroless Transseptal Puncture Technique for Lead-free Catheter Ablation: A Case Series. Journal of Innovations in Cardiac Rhythm Management. 11(4). 4079–4085. 4 indexed citations
6.
Morin, Michael J., et al.. (2016). The Human Sodium-Glucose Cotransporter (hSGLT1) Is a Disulfide-Bridged Homodimer with a Re-Entrant C-Terminal Loop. PLoS ONE. 11(5). e0154589–e0154589. 5 indexed citations
7.
Morin, Michael J., Pierre Langevin, & Philippe Fait. (2016). Cervical Spine Involvement in Mild Traumatic Brain Injury: A Review. SHILAP Revista de lepidopterología. 2016. 1–20. 43 indexed citations
8.
9.
Morin, Michael J.. (2000). From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents. Oncogene. 19(56). 6574–6583. 101 indexed citations
10.
Pollack, Vincent A., Deborah A. Baker, Konstantinos Tsaparikos, et al.. (1999). Inhibition of Epidermal Growth Factor Receptor-Associated Tyrosine Phosphorylation in Human Carcinomas with CP-358,774: Dynamics of Receptor Inhibition In Situ and Antitumor Effects in Athymic Mice. Journal of Pharmacology and Experimental Therapeutics. 291(2). 739–748. 369 indexed citations
11.
Foster, Barbara A., et al.. (1999). Pharmacological Rescue of Mutant p53 Conformation and Function. Science. 286(5449). 2507–2510. 647 indexed citations breakdown →
12.
Nathan, Debra F., et al.. (1990). Increased cell surface EGF receptor expression during the butyrate-induced differentiation of human HCT-116 colon tumor cell clones. Experimental Cell Research. 190(1). 76–84. 32 indexed citations
13.
14.
Posada, James, et al.. (1989). Human Multidrug Resistant KB Cells Overexpress Protein Kinase C: Involvement in Drug Resistance. 1(5). 285–292. 70 indexed citations
15.
Sartorelli, Alan C., et al.. (1986). Mechanisms involved in the induction of malignant cell differentiation. Advances in Enzyme Regulation. 25. 507–508. 7 indexed citations
16.
Morin, Michael J. & Alan C. Sartorelli. (1984). Inhibition of glycoprotein biosynthesis by the inducers of HL-60 cell differentiation, aclacinomycin A and marcellomycin.. PubMed. 44(7). 2807–12. 47 indexed citations
17.
Morin, Michael J., Carl W. Porter, Charles R. Petrie, W. Korytnyk, & Ralph J. Bernacki. (1983). Effects of a membrane sugar analogue, 6-deoxy-6-fluoro-d-galactose, on the L1210 leukemic cell ectosialyltransferase system. Biochemical Pharmacology. 32(3). 553–561. 10 indexed citations
18.
Morin, Michael J. & Ralph J. Bernacki. (1983). Biochemical effects and therapeutic potential of tunicamycin in murine L1210 leukemia.. PubMed. 43(4). 1669–74. 31 indexed citations
19.
Morin, Michael J., Carl W. Porter, Patricia A. McKernan, & Ralph J. Bernacki. (1983). The biochemical and ultrastructural effects of tunicamycin and D‐glucosamine in L1210 leukemic cells. Journal of Cellular Physiology. 114(2). 162–172. 36 indexed citations
20.
Sufrin, Janice R., Ralph J. Bernacki, Michael J. Morin, & W. Korytnyk. (1980). Halogenated L-fucose and D-galactose analogs: synthesis and metabolic effects. Journal of Medicinal Chemistry. 23(2). 143–149. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Tsai Breakdown of academic impact, for papers by Hisao Fukumoto Breakdown of academic impact, for papers by Christine M. Chresta Breakdown of academic impact, for papers by Masashi Aonuma Breakdown of academic impact, for papers by I Bae Breakdown of academic impact, for papers by Sheng-Chieh Hsu Breakdown of academic impact, for papers by Christine Stephan Breakdown of academic impact, for papers by Sébastien Jeay Breakdown of academic impact, for papers by Lily L. Remsing Rix Breakdown of academic impact, for papers by Donald Thornton
Rankless by CCL
2026